Exhibit 99.1 FISCAL 2025 THIRD QUARTER FINANCIAL RESULTS • Revenue: Total revenues for the third quarter of fiscal 2025 grew to $96.1 million compared to$81.5 million for the same period of fiscal 2024. ◦ SynBio revenue grew 7% to $35.2 million for the third quarter of fiscal 2025 compared to$33.0 million for the same period of fiscal 2024. ◦ NGS revenue grew 27% to $55.3 million for the third quarter of fiscal 2025 compared to$43.4 million for the same period of fiscal 2024. ◦ Biopharma revenue grew 10% ...